New dementia drugs and therapies: What Canadians should know

"There are hundreds of dementia drugs and therapies in development worldwide. But we only hear about a few of them from time to time in the news.  

What should members of the public know if they want to understand dementia drug and therapy creation better? Or if they want to know how these drugs and therapies are tested and evaluated? 

Join us online April 19 at 12 p.m. Eastern Time for a conversation with leading researchers that will embrace these questions, and more.

Speakers include 

• Dr. Sharon Cohen, Director of the Toronto Memory Program
• Dr. Serge Gauthier, Director of the Alzheimer Disease and Related Disorders Research Unit, McGill Center for Studies in Aging, Douglas Research Centre
• Dr. Howard Chertkow, Chair in Cognitive Neurology and Innovation Director at the Kimel Family Centre for Brain Health, Baycrest

The conversation will be moderated by Dr. Saskia Sivananthan, Chief Research and KTE Officer at the Alzheimer Society of Canada.

This event will take place in English with live French interpretation provided."